CNMD logo

CONMED (CNMD)

Profile

Full Name

CONMED Corporation

Ticker Symbol

CNMD

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

July 23, 1987

Indexes

Not included

Website

http://www.conmed.com

Employees

3900

Key Details

Price

$57.90

Market Cap

Last Dividend

$0.20

TTM Dividend Yield

1.38%

Annual Revenue

$1.31B(+5.00% YoY)

Annual EPS

$4.25(+108.33% YoY)

PE Ratio

13.66

Next earnings date

Apr 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$57.90
CNMD price is $57.90

Price All-time High

$157.03
CNMD price is currently -63.13% below its historical high of $157.03

Price Today Change

-4.19%
CNMD price is down -4.19% today

Price YTD Change

-15.4%
CNMD price is down -15.4% since January 1st

Price 1-year Change

-25.28%
CNMD price is down -25.28% year-on-year

Price 3-year Change

-61.35%
CNMD price is down -61.35% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$1.79B
CNMD market capitalization is $1.79 billion

Market Cap 3-year Change

-59.53%
CNMD market capitalization is down -59.53% over the past 3 years

Market Cap All-time High

$4.59B
CNMD market capitalization is currently -61.03% below its historical high of $4.59 billion

Market Cap Sector Rank

82.03%
CNMD market capitalization is higher than 82.03% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.38%
CNMD shares outstanding is up +0.38% year-on-year

Shares Outstanding 3-Year Change

+4.72%
CNMD shares outstanding is up +4.72% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.58
CNMD beta is 0.58

200-day SMA

$68.16
CNMD price is currently -15.06% below its 200-day simple moving average

50-day SMA

$63.07
CNMD price is currently -8.19% below its 50-day simple moving average

RSI

41.25
CNMD 14-day relative strength index is 41.25

Volume

1.13
CNMD 30-day relative volume is 1.13

ATR

$2.25
CNMD average true range is $2.25

10-day Historical Volatility

34.90%
CNMD 10-day historical volatility is 34.90%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.20
CNMD last dividend was $0.20 per share, with an ex-dividend date of March 14, 2025

Next Dividend

-
CNMD next dividend has not yet been announced

Dividend per share

Dividend Per Share

$0.80
CNMD annual dividend per share is $0.80

Dividend per share Sector Rank

32.56%
CNMD annual dividend per share is higher than 32.56% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
CNMD {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

0%
CNMD {parameterFullLabel} has remained unchanged over the past 3 years

Dividend yield

Dividend Yield

1.38%
CNMD annual dividend yield is 1.38%

Dividend yield Sector Rank

36.47%
CNMD annual dividend yield is higher than 36.47% of companies in Healthcare sector

Other

Payout Ratio

18.62%
CNMD annual payout ratio is 18.62%

Dividends Paid

$24.65M
CNMD annual dividends paid is $24.65 million

Free Cash Flow

$153.88M
CNMD annual free cash flow is $153.88 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.31B
CNMD annual revenue is $1.31 billion

Revenue Analysts Estimate

$1.36B
CNMD annual revenue is currently -3.71% lower than the consensus analysts' forecast

Revenue 1-year Change

+5%
CNMD annual revenue is up +5% year-on-year

Revenue Sector Rank

83.19%
CNMD annual revenue is higher than 83.19% of companies in Healthcare sector

EPS

EPS

$4.25
CNMD annual earnings per share is $4.25

EPS Analysts Estimate

$4.34
CNMD annual earnings per share is currently -2.01% lower than the consensus analysts' forecast

EPS 1-year Change

+108.33%
CNMD annual earnings per share is up +108.33% year-on-year

EPS Sector Rank

94.92%
CNMD annual earnings per share is higher than 94.92% of companies in Healthcare sector

Profit

Gross Profit

$733.03M
CNMD annual gross profit is $733.03 million

Gross Margin

56.08%
CNMD annual gross profit margin is 56.08%

Operating Profit

$200.33M
CNMD annual operating income is $200.33 million

Operating Margin

15.33%
CNMD annual operating profit margin is 15.33%

Net Income

$132.42M
CNMD annual net profit is $132.42 million

Net Margin

10.13%
CNMD annual net profit margin is 10.13%

Expenses

Total Expenses

$1.11B
CNMD annual total expenses is $1.11 billion

Operating Expenses

$532.71M
CNMD annual total operating expenses is $532.71 million

Cost Of Goods Sold

$573.98M
CNMD annual cost of goods sold is $573.98 million

Selling, General & Administrative Expenses

$478.28M
CNMD annual SGA is $478.28 million

Depreciation And Amortization

$71.86M
CNMD annual depreciation & amortization is $71.86 million

Interest Expense

$37.30M
CNMD annual interest expense is $37.30 million

Income Tax

$30.61M
CNMD annual income tax is $30.61 million

EBIT & EBITDA

EBIT

$200.33M
CNMD annual earnings before interest & taxes is $200.33 million

EBITDA

$200.33M
CNMD annual EBITDA is $200.33 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$2.31B
CNMD annual total assets is $2.31 billion

Non Current Assets

$1.67B
CNMD annual long term assets is $1.67 billion

Current Assets

$640.01M
CNMD annual total current assets is $640.01 million

Cash And Cash Equivalents

$24.46M
CNMD annual cash & cash equivalents is $24.46 million

Accounts Receivable

$237.73M
CNMD annual accounts receivable is $237.73 million

Inventory

$346.72M
CNMD annual inventory is $346.72 million

Liabilities

Total Liabilities

$1.34B
CNMD annual total liabilities is $1.34 billion

Long Term Liabilities

$1.07B
CNMD annual total long term liabilities is $1.07 billion

Current Liabilities

$278.13M
CNMD annual total current liabilities is $278.13 million

Accounts Payable

$102.25M
CNMD annual accounts payable is $102.25 million

Debt

Total Debt

$905.78M
CNMD annual total debt is $905.78 million

Total Debt 1-year Change

-6.99%
CNMD annual total debt is down -6.99% year-on-year

Long Term Debt

$905.07M
CNMD annual long term debt is $905.07 million

Short Term Debt

$715.00K
CNMD annual short term debt is $715.00 thousand

Equity & Capital

Shareholders Equity

$962.68M
CNMD annual stockholders equity is $962.68 million

Book Value

$962.68M
CNMD annual book value is $962.68 million

Retained Earnings

$560.28M
CNMD annual retained earnings is $560.28 million

Working Capital

$361.88M
CNMD annual working capital is $361.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$166.97M
CNMD annual cash flow from operations is $166.97 million

Cash From Operations 1-year Change

+33.2%
CNMD annual cash flow from operations is up +33.2% year-on-year

Cash From Investing

-$13.08M
CNMD annual cash flow from investing activities is -$13.08 million

Cash From Investing 1-year Change

+34.68%
CNMD annual cash flow from investing activities is up +34.68% year-on-year

Cash From Financing

-$151.00M
CNMD annual cash flow from financing activities is -$151.00 million

Cash From Financing 1-year Change

-36.74%
CNMD annual cash flow from financing activities is down -36.74% year-on-year

CAPEX

CAPEX

$13.08M
CNMD annual capital expenditures is $13.08 million

CAPEX 1-year Change

-31.25%
CNMD annual capital expenditures is down -31.25% year-on-year

Free Cash Flow

Free Cash Flow

$153.88M
CNMD annual free cash flow is $153.88 million

Free Cash Flow 1-year Change

+44.74%
CNMD annual free cash flow is up +44.74% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

56.08%
CNMD annual gross profit margin is 56.08%

Operating Margin

15.33%
CNMD annual operating profit margin is 15.33%

Net Margin

10.13%
CNMD annual net profit margin is 10.13%

ROA & ROE

ROA

5.75%
CNMD annual return on assets is 5.75%

ROE

14.74%
CNMD annual return on equity is 14.74%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

13.66
CNMD price to earnings ratio is 13.66

PE Ratio Sector Rank

20.39%
CNMD price to earnings ratio is higher than 20.39% of companies in Healthcare sector

PB Ratio

PB Ratio

1.86
CNMD price to book ratio is 1.86

PB Ratio Sector Rank

61.17%
CNMD price to book ratio is higher than 61.17% of companies in Healthcare sector

PS Ratio

PS Ratio

1.37
CNMD price to sales ratio is 1.37

PS Ratio Sector Rank

33.55%
CNMD price to sales ratio is higher than 33.55% of companies in Healthcare sector

Enterprise value

Enterprise Value

$2.67B
CNMD enterprise value is $2.67 billion

Enterprise Value Sector Rank

84.12%
CNMD enterprise value is higher than 84.12% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.51
CNMD EV/EBITDA is 10.51

EV/EBITDA Sector Rank

82.13%
CNMD EV/EBITDA is higher than 82.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

2.30
CNMD annual current ratio is 2.30

Quick Ratio

1.05
CNMD annual quick ratio is 1.05

Leverage

Debt To Equity

0.94
CNMD annual debt to equity ratio is 0.94

Interest Coverage Ratio

5.37
CNMD annual interest coverage ratio is 5.37

Risk & Stability

Piotroski F-Score

8
CNMD piotroski f-score is 8

Altman Z-Score

2.18
CNMD altman z-score is 2.18

Analyst ratings

Recent major analysts updates

Feb 6, 25 Wells Fargo
Equal-Weight
Feb 6, 25 Stifel
Buy
Feb 6, 25 Needham
Buy
Feb 6, 25 JP Morgan
Neutral
Oct 31, 24 Needham
Buy
Oct 4, 24 Needham
Buy
Aug 1, 24 Wells Fargo
Equal-Weight
Aug 1, 24 Stifel
Buy
Aug 1, 24 Piper Sandler
Overweight
Aug 1, 24 Needham
Buy

Institutional Ownership

Similar stocks

SUPN logo
Supernus Pharmaceuticals (SUPN)
DNLI logo
Denali Therapeutics (DNLI)
CLOV logo
Clover Health Investments (CLOV)
Ardent Health Partners LLC (ARDT)
HRMY logo
Harmony Biosciences Holdings (HRMY)
LMAT logo
LeMaitre Vascular (LMAT)
PINC logo
Premier (PINC)
NEOG logo
Neogen (NEOG)
TARS logo
Tarsus Pharmaceuticals (TARS)
  • What is the ticker symbol for CONMED?
  • Does CONMED pay dividends?
  • What sector is CONMED in?
  • What industry is CONMED in?
  • What country is CONMED based in?
  • When did CONMED go public?
  • Is CONMED in the S&P 500?
  • Is CONMED in the NASDAQ 100?
  • Is CONMED in the Dow Jones?
  • When was CONMED's last earnings report?
  • When does CONMED report earnings?
  • Should I buy CONMED stock now?

What is the ticker symbol for CONMED?

The ticker symbol for CONMED is NYSE:CNMD

Does CONMED pay dividends?

Yes, CONMED pays dividends. The last payment was $0.20, with an ex-dividend date on March 14, 2025

What sector is CONMED in?

CONMED is in the Healthcare sector

What industry is CONMED in?

CONMED is in the Medical Devices industry

What country is CONMED based in?

CONMED is headquartered in United States

When did CONMED go public?

CONMED's initial public offering (IPO) was on July 23, 1987

Is CONMED in the S&P 500?

No, CONMED is not included in the S&P 500 index

Is CONMED in the NASDAQ 100?

No, CONMED is not included in the NASDAQ 100 index

Is CONMED in the Dow Jones?

No, CONMED is not included in the Dow Jones index

When was CONMED's last earnings report?

CONMED's most recent earnings report was on Feb 5, 2025

When does CONMED report earnings?

The next expected earnings date for CONMED is Apr 24, 2025

Should I buy CONMED stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page